Cardiovascular Systems Stock Price and Value Analysis

Should you buy Cardiovascular Systems stock? (NasdaqGS:CSII). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the CSII Numbers

CSII Price
(Cardiovascular Systems stock price per share)
$18.79
[?] PE Ratio versus Sector 3828% higher than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 58%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 870,873 shares shorted. With 37,038,567 shares available for purchase and an average trading volume over the past 10 trading days of 516,000, it would take at least 1.688 days for all of the short holders to cover their shorts.

Is Cardiovascular Systems Stock on Sale?

Based on our analysis, we believe that you should not buy Cardiovascular Systems right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CSII Stock?

Does Cardiovascular Systems have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.